Abstract
Tabin has proposed a progress-zone model1, based on published data, to explain the inhibition of limb morphogenesis by thalidomide. We do not think that his model convincingly explains the main features of thalidomide action.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Tabin, C. J. Nature 396, 322–323 (1998).
Neubert, R. & Neubert, D. in Drug Toxicity in Embryonic Development (eds Kavlock, R. J. & Daston, G. P.) 44–119 (Springer, Berlin, 1997).
Streeter, G. L. Contrib. Embryol. Carneg. Inst. 31, 27–63 (1945).
Streeter, G. L. Contrib. Embryol. Carneg. Inst. 32, 133–203 (1948).
Merker, H.-J., Heger, W., Sames, K., Stürje, H. & Neubert, D. Arch. Toxicol. 61, 165–179 (1988).
Neubert, D., Heger, W., Merker, H.-J., Sames, K. & Meister, R. Arch. Toxicol. 61, 180–191 (1988).
Christ, B. et al. Anat. Embryol. 150, 171–186 (1977).
Theisen, C. T. & McGregor, E. E. Teratology 23, 65A (1981).
Neubert, R., Hinz, N., Thiel, R. & Neubert, D. Life Sci. 58, 295–316 (1996).
Neubert, R., Hinz, N. & Thiel, R. in Methods in Developmental Toxicology/Biology (eds Klug, S. & Thiel, R.) 209–226 (Blackwell, Berlin, 1997).
Springer, T. A. Nature 346, 425–434 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Neubert, R., Merker, HJ. & Neubert, D. Developmental model for thalidomide action. Nature 400, 419–420 (1999). https://doi.org/10.1038/22685
Issue Date:
DOI: https://doi.org/10.1038/22685
This article is cited by
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.